Avis Budget Group, Inc. (CAR)
$
130.59
+2.48 (1.90%)
Key metrics
Financial statements
Free cash flow per share
-280.2557
Market cap
4.5 Billion
Price to sales ratio
0.3855
Debt to equity
-11.9195
Current ratio
0.7062
Income quality
-1.8544
Average inventory
0
ROE
0.8161
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Avis Budget Group, Inc., along with its subsidiaries, provides a comprehensive range of car and truck rentals, car sharing, and ancillary services to both businesses and consumers. The company operates under the Avis brand, which delivers premium vehicle rental and mobility solutions tailored for the commercial and leisure segments of the travel industry. Furthermore, the Budget Truck brand specializes in local and one-way truck and cargo van rentals, boasting a fleet of approximately 20,000 vehicles available through a network of around 465 dealer-operated and 385 company-operated locations across the continental United States, serving consumer and light commercial needs. Additionally, the Zipcar brand enhances the offering with its car-sharing network. Avis Budget Group also manages several other car rental brands, including Budget, Payless, Apex, Maggiore, MoriniRent, FranceCars, Amicoblue, Turiscar, and ACL Hire. The company provides a variety of optional insurance products and coverages, such as supplemental liability, personal accident, personal effects protection, emergency sickness protection, and automobile towing protection, alongside cargo insurance options. Additional offerings include fuel service alternatives, roadside assistance, electronic toll collection services, curbside delivery, tablet rentals, satellite radio access, portable navigation units, and child safety seat rentals. The company also supplies moving equipment and accessories, such as hand trucks and furniture pads, as well as a Business Intelligence solution through an online portal for corporate travel. Avis Budget Group, Inc. operates in approximately 10,400 locations globally. The financial data pertains to the fiscal year 2024 during which the company recorded an operating income of $1,499,000,000.00 reflecting its earnings from core operations. The earnings per share (EPS) is reported at -$51.23 indicating the company's profitability on a per-share basis. Furthermore, the net total of other income and expenses is -$4,126,000,000.00 reflecting non-core financial activities, while the company earned an interest income of $0.00 showcasing its financial investments. In the investment landscape, the stock of Avis Budget Group, Inc. is reasonably priced at $157.66 appealing to a broad range of investors. The stock has an average trading volume of 783,298.00 indicating moderate liquidity. With a mid-range market capitalization of $4,596,375,185.00 the company is recognized as a steady performer within its domain. It is a key player in the Rental & Leasing Services industry, contributing significantly to the overall market landscape. Additionally, it belongs to the Industrials sector, driving innovation and growth.
Is Avis Budget Group, Inc. (CAR) a good investment?
Investing in Avis Budget Group, Inc. (CAR) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
What is Avis Budget Group, Inc. (CAR)'s stock forecast?
Analysts predict Avis Budget Group, Inc. stock to fluctuate between $54.03 (low) and $212.81 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Avis Budget Group, Inc.'s market capitalization?
As of 2025-12-19, Avis Budget Group, Inc.'s market cap is $4,596,375,185, based on 35,196,992 outstanding shares.
How does Avis Budget Group, Inc. compare to competitors like GE Aerospace?
Compared to GE Aerospace, Avis Budget Group, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Avis Budget Group, Inc. pay dividends?
Avis Budget Group, Inc. pays dividends. The current dividend yield is 5.19%, with a payout of $10 per share.
How can I buy Avis Budget Group, Inc. (CAR) stock?
To buy Avis Budget Group, Inc. (CAR) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CAR. Place an order (Market, Limit, etc.).
What is the best time to invest in Avis Budget Group, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Avis Budget Group, Inc. stock ever split?
Avis Budget Group, Inc.'s last stock split was 1:10 on 2006-09-05.
How did Avis Budget Group, Inc. perform in the last earnings report?
Revenue: $11,789,000,000 | EPS: -$51.23 | Growth: -220.23%.
Where can I find Avis Budget Group, Inc.'s investor relations reports?
Visit https://www.avisbudgetgroup.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Avis Budget Group, Inc.?
You can explore historical data from here
What is the all-time high and low for Avis Budget Group, Inc. stock?
All-time high: $545.11 (2021-11-02) | All-time low: $54.03 (2025-03-13).
What are the key trends affecting Avis Budget Group, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
youtube.com
Valvoline CEO Lori Flees discusses the used car boom, decreased interest in electric vehicles and more on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #theclamancountdown #foxbusiness #valvoline #ev #electricvehicles #usedcars #autos #cars #market #economy #business #transportation #energy #trump #donaldtrump
fool.com
Toronto-based Maple Rock Capital Partners sold 415,584 shares of Avis Budget Group in the third quarter. The move marked a full exit for Maple Rock, effectively eliminating a position previously valued at $70.3 million.
globenewswire.com
SOMERSET, N.J., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced new long-term clinical and translational data for CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) from the CARTITUDE-1 and CARTITUDE-4 studies in relapsed / refractory multiple myeloma (RRMM) patients. In triple-class-exposed patients who had received three prior lines of therapy, a median progression-free survival (mPFS) of 50.4 months was observed following a single infusion of CARVYKTI®. This represents one of the longest PFS outcomes reported for a BCMA-targeted CAR-T cell therapy in this heavily pretreated population.
businesswire.com
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL).
zacks.com
Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
businesswire.com
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma.
globenewswire.com
NOVEL THREE-PART ONLINE AUCTION TO INCLUDE EUROPE AND UK-BASED COLLECTOR CARS ALONGSIDE MOTORSPORT MEMORABILIA | HIGHLY ORIGINAL 1971 LAMBORGHINI MIURA P400 S LEADS EARLY COLLECTOR CAR HIGHLIGHTS | LIVE PREVIEW OPPORTUNITIES ACROSS MULTIPLE COUNTRIES TO BE ANNOUNCED | BIDDING OPENS JANUARY 23, 2026 NOVEL THREE-PART ONLINE AUCTION TO INCLUDE EUROPE AND UK-BASED COLLECTOR CARS ALONGSIDE MOTORSPORT MEMORABILIA | HIGHLY ORIGINAL 1971 LAMBORGHINI MIURA P400 S LEADS EARLY COLLECTOR CAR HIGHLIGHTS | LIVE PREVIEW OPPORTUNITIES ACROSS MULTIPLE COUNTRIES TO BE ANNOUNCED | BIDDING OPENS JANUARY 23, 2026
zacks.com
CAR's third-quarter 2025 earnings and revenues top estimates, yet the stock slides 11% as investors react to mixed segmental results.
defenseworld.net
Y Intercept Hong Kong Ltd bought a new position in Avis Budget Group, Inc. (NASDAQ: CAR) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 7,674 shares of the business services provider's stock, valued at approximately $1,297,000. Other hedge funds have
globenewswire.com
BERKELEY, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that it will hold a webcast beginning at 8:00 am ET on Monday, November 3, 2025, to report new data from the ANTLER phase 1 clinical trial evaluating vispacabtagene regedleucel (vispa-cel; formerly CB-010), an allogeneic anti-CD19 CAR-T cell therapy, in patients with relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL) and report the first clinical data from the CaMMouflage Phase 1 clinical trial evaluating CB-011, an allogeneic anti-BCMA CAR-T cell therapy, in patients with r/r multiple myeloma. The Company will also report its anticipated pivotal phase 3 trial design for vispa-cel and next steps for the continued clinical development of CB-011.
See all news
